NATCO PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,028 INR | +0.66% |
|
+2.85% | +26.69% |
| Apr. 09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
| Mar. 27 | NATCO Pharma Limited Announces Board Appointments | CI |
Presentation Operator MessageOperator (Operator)Dear shareholders, good morning, and a very wa...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with focus on research and development. The Company is engaged in in the development, manufacturing and commercialization of complex pharmaceuticals that target specific therapeutic areas. It specializes in catering to niche markets and offering solutions to address complex medical needs. It owns nine manufacturing facilities across India and two research centers in Telangana. The Companyâs segment includes Pharmaceuticals and Agro chemicals. Its Pharmaceuticals segment is engaged in manufacturing and selling of bulk drugs, finished dosage formulations and related services. Its Agro Chemicals is engaged in manufacturing and selling of agro chemical. It manufactures active pharmaceutical ingredients products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe, and United States of America.
Sector
Pharmaceuticals
Calendar
2024-05-26
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,028
INR
Average target price
975.4
INR
Spread / Average Target
-5.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.69% | 2.21B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Transcript : NATCO Pharma Limited - Shareholder/Analyst Call
